chr9-114195977-G-C

Variant summary

Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PP3PP5_Very_Strong

The NM_032888.4(COL27A1):​c.2089G>C​(p.Gly697Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000576 in 1,614,062 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: 𝑓 0.00032 ( 1 hom., cov: 33)
Exomes 𝑓: 0.000031 ( 0 hom. )

Consequence

COL27A1
NM_032888.4 missense

Scores

12
6
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: 6.17

Publications

13 publications found
Variant links:
Genes affected
COL27A1 (HGNC:22986): (collagen type XXVII alpha 1 chain) This gene encodes a member of the fibrillar collagen family, and plays a role during the calcification of cartilage and the transition of cartilage to bone. The encoded protein product is a preproprotein. It includes an N-terminal signal peptide, which is followed by an N-terminal propetide, mature peptide and a C-terminal propeptide. The N-terminal propeptide contains thrombospondin N-terminal-like and laminin G-like domains. The mature peptide is a major triple-helical region. The C-terminal propeptide, also known as COLFI domain, plays crucial roles in tissue growth and repair. Mutations in this gene cause Steel syndrome. Alternatively spliced transcript variants have been found, but the full-length nature of some variants has not been determined. [provided by RefSeq, Sep 2014]
COL27A1 Gene-Disease associations (from GenCC):
  • Steel syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 9 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.817
PP5
Variant 9-114195977-G-C is Pathogenic according to our data. Variant chr9-114195977-G-C is described in ClinVar as Pathogenic. ClinVar VariationId is 143245.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL27A1NM_032888.4 linkc.2089G>C p.Gly697Arg missense_variant Exon 7 of 61 ENST00000356083.8 NP_116277.2 Q8IZC6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL27A1ENST00000356083.8 linkc.2089G>C p.Gly697Arg missense_variant Exon 7 of 61 1 NM_032888.4 ENSP00000348385.3 Q8IZC6-1
COL27A1ENST00000451716.5 linkc.1876G>C p.Gly626Arg missense_variant Exon 4 of 8 1 ENSP00000391328.1 Q5T1U7
COL27A1ENST00000494090.6 linkn.982G>C non_coding_transcript_exon_variant Exon 4 of 58 1 ENSP00000432928.1 H0YD40

Frequencies

GnomAD3 genomes
AF:
0.000315
AC:
48
AN:
152206
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00288
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.0000278
AC:
7
AN:
251432
AF XY:
0.0000442
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.0000308
AC:
45
AN:
1461738
Hom.:
0
Cov.:
32
AF XY:
0.0000303
AC XY:
22
AN XY:
727170
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33476
American (AMR)
AF:
0.000581
AC:
26
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53408
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111876
Other (OTH)
AF:
0.000298
AC:
18
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000315
AC:
48
AN:
152324
Hom.:
1
Cov.:
33
AF XY:
0.000403
AC XY:
30
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41578
American (AMR)
AF:
0.00288
AC:
44
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68034
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000282
Hom.:
0
Bravo
AF:
0.000759
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Steel syndrome Pathogenic:5
Feb 01, 2022
Revvity Omics, Revvity
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 02, 2014
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

Segregates with the phenotype in an affected family -

Jul 02, 2014
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Sep 29, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: COL27A1 c.2089G>C (p.Gly697Arg) results in a non-conservative amino acid change located in the Collagen triple helix repeat (IPR008160) of the encoded protein sequence and disrupts a Gly residue at position 1 of a Gly-X-Y motif. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00013 in 396206 control chromosomes, predominantly at a frequency of 0.00096 within the Latino subpopulation in the gnomAD database, including 1 homozygote (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance, although studies have demonstrated that the variant of interest likely represents a founder mutation in individuals of Puerto Rican descent and that Steel syndrome can go undiagnosed (e.g., Belbin_2017). c.2089G>C has been reported in the literature in multiple homozygous individuals affected with Steel syndrome, primarily those of Puerto Rican or Hispanic/Latino descent (e.g., Gonzaga_Jauregui_2015, Belbin_2017). Additionally, individuals harboring the variant in the heterozygous state were reported to display an increased incidence of milder forms of musculoskeletal disease, including joint and spine degeneration, than non-carriers (e.g., Belbin_2017). These data indicate that the variant is very likely to be associated with autosomal recessive disease, but could lead to mild symptoms in heterozygous individuals as well. At least one publication reports experimental evidence evaluating an impact on protein function, finding that a murine model of the variant recapitulates many Steel-syndrome associated features (e.g., Gonzaga-Jauregui_2020). The following publications have been ascertained in the context of this evaluation (PMID: 28895531, 24986830, 32376988). Four submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -

not provided Pathogenic:2
Mar 16, 2022
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Published functional studies demonstrate the variant causes abnormal collagen deposition in the extracellular matrix (Gonzaga-Jauregui et el., 2020); This variant is associated with the following publications: (PMID: 24986830, 31903681, 32376988, 28895531) -

Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 697 of the COL27A1 protein (p.Gly697Arg). This variant is present in population databases (rs140950220, gnomAD 0.01%). This missense change has been observed in individuals with Steel syndrome (PMID: 24986830, 31903681). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 143245). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt COL27A1 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -

COL27A1-related disorder Pathogenic:1
Jul 08, 2024
PreventionGenetics, part of Exact Sciences
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The COL27A1 c.2089G>C variant is predicted to result in the amino acid substitution p.Gly697Arg. This variant has been reported in the homozygous state in several individuals with Steel syndrome and is a well-documented as a founder variant in individuals of Puerto Rican ancestry (see for example, Gonzaga-Jauregui et al 2015. PubMed ID: 24986830; Belbin et al 2017. PubMed ID: 28895531; Amlie-Wolf et al 2020. PubMed ID: 31903681; Gonzaga-Jauregui et al 2020. PubMed ID: 32376988). This variant is reported in 0.017% of alleles in individuals of Latino descent in gnomAD. This variant is interpreted as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.71
BayesDel_addAF
Pathogenic
0.34
D
BayesDel_noAF
Pathogenic
0.51
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.59
D;D
Eigen
Pathogenic
0.84
Eigen_PC
Pathogenic
0.77
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.97
D;D
M_CAP
Pathogenic
0.88
D
MetaRNN
Pathogenic
0.82
D;D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Pathogenic
4.0
H;.
PhyloP100
6.2
PrimateAI
Uncertain
0.75
T
PROVEAN
Pathogenic
-6.8
D;D
REVEL
Pathogenic
0.97
Sift
Uncertain
0.0020
D;D
Sift4G
Uncertain
0.0020
D;D
Polyphen
1.0
D;D
Vest4
0.91
MutPred
0.95
Gain of MoRF binding (P = 0.0156);.;
MVP
0.83
MPC
0.13
ClinPred
0.98
D
GERP RS
5.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.90
gMVP
0.92
Mutation Taster
=80/20
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140950220; hg19: chr9-116958257; API